Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension

European Respiratory Journal

Volumn 36, Issue 5, 2010, Pages 1209-1211

  Gambaryan, N ^a,b,c   Perros, F ^a,b,c   Montani, D ^a,b,c   Cohen Kaminsky, S ^a,b,c   Mazmanian, G M ^a,c   Humbert, M ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE MARROW; CONTROLLED STUDY; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; LETTER; MALE; MOUSE; NONHUMAN; ONCOGENE C KIT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STEM CELL; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANOXIA; BONE MARROW CELLS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HYPERTENSION, PULMONARY; MALE; MICE; MICE, INBRED C57BL; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES;

EID: 78349285201     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00052210     Document Type: Letter

References (10)

1. Fadini GP, Avogaro A, Ferraccioli G, et al. Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. Eur Respir J 2010; 35: 418-425.
2. Davie NJ, Crossno JT Jr, Frid MG, et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am J Physiol Lung Cell Mol Physiol 2004; 286: L668-L678.
3. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 2006; 168: 659-669.
4. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med 1991; 174: 63-71.
5. Schermuly RT, Dony E, Ghofrani HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005; 115: 2811-2821.
6. Souza R, Sitbon O, Parent F, et al. Long term imatinib treatment in pulmonary arterial hypertension. Thorax 2006; 61: 736. (Pubitemid 44211786)
7. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005; 353: 1412-1413. (Pubitemid 41362714)
8. Bartolovic K, Balabanov S, Hartmann U, et al. Inhibitory effect of imatinib on normal progenitor cells in vitro. Blood 2004; 103: 523-529. (Pubitemid 38140082)
9. Agis H, Jaeger E, Doninger B, et al. In vivo effects of imatinib mesylate on human haematopoietic progenitor cells. Eur J Clin Invest 2006; 36: 402-408.
10. Perros F, Montani D, Dorfmuller P, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 178: 81-88. (Pubitemid 351919196)